Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease

NCT03591874 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

59

Enrollment

INDUSTRY

Sponsor class

Stopped Primary endpoint was not met.

Conditions

Graft Versus Host Disease
Ocular Surface Disease
oGVHD
Ocular Graft vs Host Disease
Brimonidine Tartrate
Lubricant Eye Drops
Ophthalmic Solutions
Graft vs Host Disease

Interventions

DRUG: Brimonidine Tartrate
DRUG: Placebos

Sponsor

Ocugen